Skip to main content
Equibles

Dr. Howard Doong

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Dr. Howard Doong

Dr. Howard Doong was last confirmed as CEO at Abvc Biopharma, Inc. (ABVC) in a filing dated December 29, 2023. Earlier roles on record: CEO at Abvc Biopharma, Inc. (ABVC) until June 21, 2023. Abvc Biopharma, Inc. reported in an 8-K filed June 23, 2023 that Dr. Howard Doong resigned as Chief Executive Officer, effective June 21, 2023.

“Dr. Howard Doong, the Chief Executive Officer ("CEO") of ABVC BioPharma, Inc. (the "Company"), notified the Company of his resignation, effective June 21, 2023.”
Abvc Biopharma, Inc. Form 8-K, filed June 23, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.